New Frontiers in Liquid Biopsy
nRichDX participated in the NIH/NCI meeting “New Frontiers in Liquid Biopsy Meeting - Data, Technology and Translational Potential” in Bethesda, Maryland.
New Frontiers in Liquid Biopsy
The “New Frontiers in Liquid Biopsy Meeting - Data, Technology and Translational Potential” was held May 13-14, 2024 at the National Institutes of Health campus in Bethesda, Maryland.
The meeting was held in the Natcher Auditorium in Building 45.
nRichDX was on-site in the Bethesda area May 13-14 and participated in the scientific program through a poster presentation.
Large-Volume Urine cfDNA Research
nRichDX Chief Science Officer Nafiseh Jafari, PhD attended the meeting and presented scientific research.
Nafiseh Jafari, PhD
Chief Science Officer, nRichDX.
Whole Urine
Research focused on cell-free DNA extraction from large whole urine volumes.
Cell-Free DNA
The presentation examined enhanced cfDNA extraction from large-volume urine samples.
Prostate Cancer Detection
The research evaluated implications for prostate cancer detection.
Enhanced Cell-Free DNA Extraction from Large Whole Urine Volumes
Enhanced Cell-Free DNA Extraction from Large Whole Urine Volumes: Implications for Prostate Cancer Detection
Presented by Nafiseh Jafari, PhD, Chief Science Officer at nRichDX.
Explore nRichDX Urine Liquid Biopsy Resources
The NIH/NCI poster focused specifically on enhanced extraction of cell-free DNA from large whole urine volumes and its implications for prostate cancer detection.
Additional nRichDX resources cover urine sample preparation, liquid biopsy workflows, publications, posters, and collaborative research.
Enhanced extraction from large whole urine volumes.
- Whole Urine
- cfDNA
- Prostate Cancer
NIH/NCI Liquid Biopsy 2024 has concluded.
Explore current nRichDX news, research resources, and liquid biopsy sample preparation solutions.